ROCK & ASSOCIATES for WELLNESS PHARMACY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Health Issues HCR
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Budget/Appropriations BUD
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.